AlphaFold3 (2 articles)

AlphaFold 3 Breaks Through "Dynamic Prediction" Barrier for Protein Complexes: Nature Cover-Level Accuracy Soars, Yet Trapped in Drug Development "Translation Black Hole"?

Google DeepMind's AlphaFold 3 achieves breakthrough in predicting dynamic interactions of complex protein assemblies with over 50% accuracy improvement, but faces significant challenges in translating these advances into practical drug development applications.

DeepMind AlphaFold 3 Pioneers AI-Designed Cancer Drug in Clinical Trial: AI Pharma's Qualitative Leap from Prediction to Creation

DeepMind's AlphaFold 3 has achieved a milestone with its first AI-designed cancer drug DM-301 entering Phase I clinical trials, marking the transition of AI in drug discovery from auxiliary tool to independent creator.